Pharmacoeconomics: Open Access

The Role of a Single Dose of Pneumo-23 Vaccine in Preventing Recurrent Respiratory Tract Infection in Patients of Tertiary Public Infectious Diseases/ Immunodeficiencyâ??s Ambulatory.

Abstract

Luiz Euribel Prestes Carneiro

Pneumococcal infection (PI) is one of the most important causes of recurrent respiratory infections. The 23-valent pneumococcal polysaccharide vaccine (PPV23) has been demonstrated cost-effective in reducing the burden of PI. Following immunization with a single dose of PPV23, we track the clinical and serological reaction of individuals diagnosed with recurrent respiratory tract infections.